Botswana vs Myanmar: HIV/AIDS deaths averted by antiretroviral therapy
Botswana
9,751 deaths
in 2024
Myanmar
8,848 deaths
in 2024
Botswana rank
25th
Myanmar rank
26th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Botswana
- Myanmar
How they compare
Botswana currently reports 9,751 deaths against 8,848 deaths in Myanmar, a difference of 903 deaths.
That makes Botswana's figure about 1.1 times Myanmar's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Myanmar ahead.
Botswana ranks 25th and Myanmar ranks 26th of 157 countries.
Botswana has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Botswana | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.78 deaths | 0 deaths | 14.78 deaths | Botswana |
| 2000s | 7,590 deaths | 792.59 deaths | 6,798 deaths | Botswana |
| 2010s | 14,708 deaths | 7,079 deaths | 7,629 deaths | Botswana |
| 2020s | 10,907 deaths | 9,387 deaths | 1,520 deaths | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Botswana or Myanmar?
- Botswana, at 9,751 deaths against 8,848 deaths in Myanmar as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Botswana and Myanmar?
- 903 deaths, with Botswana ahead.
- How many years of comparable data are there for Botswana and Myanmar?
- 35 years are reported by both, from 1990 to 2024.
- How do Botswana and Myanmar rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Botswana ranks 25th and Myanmar ranks 26th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.